UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis

Digestive and liver disease, 2021-02, Vol.53 (2), p.153-157

2021

Volltextzugriff (PDF)

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review

Molecular diagnosis & therapy, 2022-03, Vol.26 (2), p.203-227

2022

Volltextzugriff (PDF)

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Nature communications, 2024-02, Vol.15 (1), p.1199-1199, Article 1199

2024

Volltextzugriff (PDF)

Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors

BMC medicine, 2022-11, Vol.20 (1), p.435-435, Article 435

2022

Volltextzugriff (PDF)

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients

BMC medicine, 2020-08, Vol.18 (1), p.232-232, Article 232

2020

Volltextzugriff (PDF)

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions

Frontiers of medicine, 2023-02, Vol.17 (1), p.18-42

2023

Volltextzugriff (PDF)

Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies

PloS one, 2018-08, Vol.13 (8), p.e0202674-e0202674

2018

Volltextzugriff (PDF)

Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors

Journal for immunotherapy of cancer, 2024-01, Vol.12 (1), p.e007959

2024

Volltextzugriff (PDF)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC

Frontiers in immunology, 2021-12, Vol.12, p.788985-788985

2021

Volltextzugriff (PDF)

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

Signal transduction and targeted therapy, 2022-10, Vol.7 (1), p.346-346, Article 346

2022

Volltextzugriff (PDF)

All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity[S]

Journal of lipid research, 2015-03, Vol.56 (3), p.537-545

2015

Volltextzugriff (PDF)

Re: “Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score–Matching Analysis”

Journal of vascular and interventional radiology, 2022-04, Vol.33 (4), p.461-462

2022

Volltextzugriff (PDF)

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

Thoracic cancer, 2022-05, Vol.13 (9), p.1289-1298

2022

Volltextzugriff (PDF)

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer

Thoracic cancer, 2021-06, Vol.12 (11), p.1743-1751

2021

Volltextzugriff (PDF)

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer

Thoracic cancer, 2021-10, Vol.12 (20), p.2732-2739

2021

Volltextzugriff (PDF)

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations

Expert opinion on therapeutic patents, 2014-07, Vol.24 (7), p.791-800

2014

Volltextzugriff (PDF)

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

British journal of cancer, 2018-08, Vol.119 (5), p.538-545

2018

Volltextzugriff (PDF)

Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling

The FASEB journal, 2023-02, Vol.37 (2), p.e22740-n/a

2023

Volltextzugriff (PDF)

SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis

Autophagy, 2024-04, Vol.20 (4), p.735-751

2024

Volltextzugriff (PDF)

Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review

Clinical cardiology (Mahwah, N.J.), 2023-03, Vol.46 (3), p.260-268

2023

Volltextzugriff (PDF)

JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.18-18, Article 18

2024

Volltextzugriff (PDF)

Organic–Inorganic Heterointerface-Expediting Electron Transfer Realizes Efficient Plasmonic Catalytic Sterilization via a Carbon-Dot Nanozyme

ACS applied materials & interfaces, 2024-05, Vol.16 (17), p.21689-21698

2024

Volltextzugriff (PDF)

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

Journal of thoracic oncology, 2020-04, Vol.15 (4), p.556-567

2020

Volltextzugriff (PDF)

Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a

Biochimica et biophysica acta. Molecular basis of disease, 2024-06, Vol.1870 (5), p.167140-167140, Article 167140

2024

Volltextzugriff (PDF)

OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytes

Biochimica et biophysica acta. Molecular basis of disease, 2024-03, Vol.1870 (3), p.167018-167018, Article 167018

2024

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(166)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(133)
Humans
(101)
Animals
(55)
Male
(34)
Female
(30)
Biochemistry & Molecular Biology
(28)
Mice
(27)
Oncology
(21)
Middle Aged
(19)
Aged
(18)
Cell Biology
(17)
Physical Sciences
(17)
Technology
(17)
Chemistry
(16)
Mutation
(16)
Patients
(15)
Retrospective Studies
(14)
Science & Technology - Other Topics
(14)
Tumors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions

Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies

Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity[S]

Re: “Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score–Matching Analysis”

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling

SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis

Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review

JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes

Organic–Inorganic Heterointerface-Expediting Electron Transfer Realizes Efficient Plasmonic Catalytic Sterilization via a Carbon-Dot Nanozyme

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a

OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytes

Aktive Filter

Suchergebnisse filtern